James B. Tananbaum bought $3.1M of ALMS
director, owner at ALUMIS INC.. 507,874 shares at an average of $6.09, traded Nov 17, 2025, filed Nov 19, 2025.
Score components
- +15RoleDirector
- +25Trade size$3.1M at market
- +6Relative to holdingsHoldings up 25%
- +8Price context46% below the 52-week high
- +15Cluster4 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +71.8%, 3m +318.7%, 6m +235.5%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001104659-25-114266, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Nov 17, 2025 | POpen-market purchase Common Stockindirect: See Footnote | +50,000 | $5.60 | $280k | 2,084,129 | Nov 19, 2025 |
| Nov 17, 2025 | POpen-market purchase Common Stockindirect: See Footnote | +150,000 | $5.59 | $839k | 2,234,129 | Nov 19, 2025 |
| Nov 18, 2025 | POpen-market purchase Common Stockindirect: See Footnote | +117,374 | $6.19 | $727k | 2,351,503 | Nov 19, 2025 |
| Nov 19, 2025 | POpen-market purchase Common Stockindirect: See Footnote | +190,500 | $6.56 | $1.2M | 2,542,003 | Nov 19, 2025 |
Related signals
Other insiders at ALUMIS INC. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 46Moderate | ALMSbuy ALUMIS INC. | Srinivas Akkaraju director | $11M 986,721 shares | +22% | |
| 40Moderate | ALMSsell ALUMIS INC. | Srinivas Akkaraju director | $1.0M 96,131 shares | -2% | |
| 38Weak | ALUMIS INC. | Roy C. Hardiman Chief Business & Strategy Ofcr | $71k 2,692 shares | -1% | |
| 51Moderate | ALUMIS INC. | John R. Schroer Chief Financial Officer | $87k 3,282 shares | -12% | |
| 38Weak | ALUMIS INC. | David M Goldstein Chief Scientific Officer | $68k 2,596 shares | -8% | |
| 38Weak | ALUMIS INC. | Jorn Drappa Chief Medical Officer | $65k 2,447 shares | -4% | |
| 38Weak | ALUMIS INC. | Mark Christopher Bradley Chief Development Officer | $68k 2,572 shares | -5% | |
| 41Moderate | ALUMIS INC. | Sanam Pangali Chief Legal Officer | $36k 1,364 shares | -12% | |
| 21Weak | ALMSsell ALUMIS INC. | Sanam Pangali Chief Legal Officer | $140k 5,000 shares | -31% | |
| 66Notable | ALUMIS INC. | Srinivas Akkaraju director | $10.0M 588,235 shares | +46% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.